866-997-4948(US-Canada Toll Free)

Global Market Study on Humanized Mice Model: Biotechnology Companies to Gear Up in Terms of Adoption Research and Development Emerging at Rapid Pace as the Need of the Hour

Published By :

Persistence Market Research

Published Date : Apr 2018

Category :

Pharmaceutical

No. of Pages : 157 Pages

Immuno-deficient mice models have attracted groundswell of interest of researchers and industry players for expanding understanding of human infectious diseases, various cancer types, regenerative therapies, and in immune studies. Novel approaches have paved way to rapid progress in the study of humanized mice models for getting insights into human immune response. To this end, growing number of cost-effective humanized mice platforms and services bodes well. Rising research funding in the life science industries are underpinning exciting frontiers, helping the market to reach worth of US$113.5 million by 2027 end.



Request summary of this Report

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Outlook of the humanized mice model market with reference to the healthcare life sciences sector

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

  • Current expenditure on health, % of gross domestic product
  • Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
  • Annual growth rate of current expenditure on health, per capita, in real terms
  • Out-of-pocket expenditure, % of current expenditure on health
  • Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
  • Physicians, Density per 1000 population (head counts)
  • Nurses, Density per 1000 population (head counts)
  • Total hospital beds, per 1000 population
  • Curative (acute) care beds, per 1000 population
  • Medical technology, Magnetic Resonance Imaging units, total, per million population
  • Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

PMR utilizes a triangulation methodology that is primarily based on overall expenditure on life science research and R&D funding and capital equipment installed base to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country-specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of kits, reagents and consumables among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side respondents such as laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project year-on-year growth rates. These Y-o-Y growth projections are checked and aligned as per associated industry/product lifecycles and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse annual reports of various companies, investor presentations, SEC filings, 10k reports and earning call transcripts operating in the market to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier-level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as overall life science research expenditure, R&D funding, industry based demand driving factors impacting the market and its forecast trends apart from other macroeconomic factors.

Standard Report Structure

  • Executive Summary
  • Market Definition
  • Macro-economic analysis
  • Parent Market Analysis
  • Market Overview
  • Forecast Factors
  • Segmental Analysis and Forecast
  • Regional Analysis
  • Competition Analysis

Target Audience

Production Companies

  • Suppliers
  • Channel Partners
  • Marketing Authorities
  • Subject Matter Experts
  • Research Institutions
  • Financial Institutions
  • Market Consultants
  • Government Authorities
  • Market Taxonomy

The global humanized mice model has been segmented into:

Model Type

  • Genetic Humanized Mice Model
  • Cell-Based Humanized Mice Model
  • CD-34
  • PBMC

End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutes

Application

  • Toxicology
  • Oncology
  • Infectious Diseases
  • GvHD
  • Regenerative Medicine
  • Neurobiology
  • Others

Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Table of Content

1. Global Humanized Mouse Model Market - Executive Summary

2. Research Methodology

3. Assumptions and Acronyms Used

4. Global Humanized Mouse Model Market Overview

4.1. Introduction
4.1.1. Humanized Mouse Model Market Taxonomy
4.1.2. Humanized Mouse Model Market Definition
4.2. Global Humanized Mouse Model Market Dynamics
4.2.1. Macro-economic Factors
4.2.2. Drivers
4.2.3. Restraints
4.2.4. Opportunities
4.2.5. Market Trends
4.3. Drivers and Restraints: Impact Analysis
4.4. Global Humanized Mouse Model Market Size and Forecast
4.4.1. Global Humanized Mouse Model Market Y-o-Y Growth
4.4.2. Global Humanized Mouse Model Market Absolute $ Opportunity

5. Global Humanized Mouse Model Market Analysis and Forecast, By Model Type
5.1. Introduction
5.1.1. Market Share Analysis By Model Type
5.1.2. Y-o-Y Growth Projections By Model Type
5.2. Market Size (US$ Mn) Forecast By Model Type
5.2.1. Genetic Humanized Mice Model
5.2.2. Cell-Based Humanized Mice Model
5.2.2.1. CD-34
5.2.2.1. PBMC
5.3. Market Attractiveness Analysis By Model Type

6. Global Humanized Mouse Model Market Analysis and Forecast, By Application
6.1. Introduction
6.1.1. Market Share Analysis By Application
6.1.2. Y-o-Y Growth Projections By Application
6.2. Market Size (US$ Mn) Forecast By Application
6.2.1. Toxicology
6.2.2. Oncology
6.2.3. Infectious Disease
6.2.4. GvHD
6.2.5. Regenerative Medicine
6.2.6. Neurobiology
6.2.7. Others
6.3. Market Attractiveness Analysis By Application

7. Global Humanized Mouse Model Market Analysis Forecast, By End User
7.1. Introduction
7.1.1. Market Share Analysis By End User
7.1.2. Y-o-Y Growth Projections By End User
7.2. Market Size (US$ Mn) and Forecast By End User
7.2.1. Pharmaceuticals & Biotechnology Companies
7.2.2. Contract Research Organizations (CROs)
7.2.3. Academic & Research Institutions
7.3. Market Attractiveness Analysis By End User

8. Global Humanized Mouse Model Market Analysis and Forecast, By Region
8.1. Introduction
8.1.1. Market Share Analysis By Region
8.1.2. Y-o-Y Growth Projections By Region
8.2. Market Size (US$ Mn) and Forecast By Region
8.2.1. North America
8.2.2. Latin America
8.2.3. Europe
8.2.4. Asia Pacific
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis By Region

9. North America Humanized Mouse Model Market Analysis and Forecast
9.1. Introduction
9.1.1. Market Share Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.2. Market Size (US$ Mn) Forecast By Country
9.2.1. U.S.
9.2.2. Canada
9.3. Market Size (US$ Mn) Forecast By Model Type
9.3.1. Genetic Humanized Mice Model
9.3.2. Cell-Based Humanized Mice Model
9.3.2.1. CD-34
9.3.2.2. PBMC
9.4. Market Size (US$ Mn) Forecast By Application
9.4.1. Toxicology
9.4.2. Oncology
9.4.3. Infectious Disease
9.4.4. GvHD
9.4.5. Regenerative Medicine
9.4.6. Neurobiology
9.4.7. Others
9.5. Market Size (US$ Mn) and Forecast By End User
9.5.1. Pharmaceuticals & Biotechnology Companies
9.5.2. Contract Research Organizations (CROs)
9.5.3. Academic & Research Institutions
9.6. Market Attractiveness Analysis
9.6.1. By Country
9.6.2. By Product Type
9.6.3. By Application
9.6.4. By End User

10. Latin America Humanized Mouse Model Market Analysis and Forecast
10.1. Introduction
10.1.1. Market Share Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2. Market Size (US$ Mn) and Forecast By Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Market Size (US$ Mn) Forecast By Model Type
10.3.1. Genetic Humanized Mice Model
10.3.2. Cell-Based Humanized Mice Model
10.3.2.1. CD-34
10.3.2.2. PBMC
10.2. Market Size (US$ Mn) Forecast By Application
10.4.1. Toxicology
10.4.2. Oncology
10.4.3. Infectious Disease
10.4.7. Others
10.4.5. Regenerative Medicine
10.4.6. Neurobiology
10.4.7. Others
10.5. Market Size (US$ Mn) and Forecast By End User
10.5.1. Pharmaceuticals & Biotechnology Companies
10.5.2. Contract Research Organizations (CROs)
10.5.3. Academic & Research Institutions
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product Type
10.6.3. By Application
10.6.4. By End User

11. Europe Humanized Mouse Model Market Analysis and Forecast
11.1. Introduction
11.1.1. Market Share Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2. Market Size (US$ Mn) and Forecast By Country
11.2.1. Germany
11.2.2. France
11.2.3. U.K.
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Market Size (US$ Mn) Forecast By Model Type
11.3.1. Genetic Humanized Mice Model
11.3.2. Cell-Based Humanized Mice Model
11.3.2.1. CD-34
11.3.2.2. PBMC
11.4. Market Size (US$ Mn) Forecast By Application
11.4.1. Toxicology
11.4.2. Oncology
11.4.3. Infectious Disease
11.4.4. GvHD
11.4.5. Regenerative Medicine
11.4.6. Neurobiology
11.4.7. Others
11.5. Market Size (US$ Mn) and Forecast By End User
11.5.1. Pharmaceuticals & Biotechnology Companies
11.5.2. Contract Research Organizations (CROs)
11.5.3. Academic & Research Institutions
11.6. Market Attractiveness Analysis
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By Application
11.6.4. By End User

12. Asia Pacific Humanized Mouse Model Market Analysis and Forecast
12.1. Introduction
12.1.1. Market Share Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2. Market Size (US$ Mn) and Forecast By Country
12.2.1. China
12.2.2. India
12.2.3. Japan
12.2.4. ASEAN
12.2.5. Australia & New Zealand
12.2.6. Rest of Asia Pacific
12.2. Market Size (US$ Mn) Forecast By Model Type
12.2.1. Genetic Humanized Mice Model
12.2.2. Cell-Based Humanized Mice Model
12.2.2.1. CD-34
12.2.2.2 PBMC
12.3. Market Size (US$ Mn) Forecast By Application
12.3.1. Toxicology
12.3.2. Oncology
12.3.3. Infectious Disease
12.3.4. GvHD
12.3.5. Regenerative Medicine
12.3.6. Neurobiology
12.3.7. Others
12.5. Market Size (US$ Mn) and Forecast By End User
12.5.1. Pharmaceuticals & Biotechnology Companies
12.5.2. Contract Research Organizations (CROs)
12.5.3. Academic & Research Institutions
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Product Type
12.6.3. By Application
12.6.4. By End User

13. MEA Humanized Mouse Model Market Analysis and Forecast
13.1. Introduction
13.1.1. Market Share Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2. Market Size (US$ Mn) and Forecast By Country
13.2.1. GGC Countries
13.2.2. South Africa
13.2.3. Rest of MEA
13.2. Market Size (US$ Mn) Forecast By Model Type
13.2.1. Genetic Humanized Mice Model
13.2.2. Cell-Based Humanized Mice Model
13.2.2.1. CD-34
13.2.2.2. PBMC
13.4. Market Size (US$ Mn) Forecast By Application
13.4.6. Toxicology
13.4.2. Oncology
13.4.3. Infectious Disease
13.4.4. GvHD
13.4.5. Regenerative Medicine
13.4.6. Neurobiology
13.4.7. Others
13.5. Market Size (US$ Mn) and Forecast By End User
13.5.1. Pharmaceuticals & Biotechnology Companies
13.5.2. Contract Research Organizations (CROs)
13.5.3. Academic & Research Institutions
13.6. Market Attractiveness Analysis
13.6.1. By Country
13.6.2. By Product Type
13.6.3. By Application
13.6.4. By End User

14. Competitive Landscape (Revenue, Product Offerings, Highlights)
14.1. THE JACKSON LABORATORY
14.2. Taconic Biosciences, Inc.
14.3. Genoway S.A.
14.4. Yecuris Corporation
14.5. Charles River Laboratories, Inc.
14.6. Crown Bioscience Inc.
14.7. Ingenious Targeting Laboratory Inc.
14.8 Horizon Discovery Group plc
14.9. HuMurine Technologies
14.10. Trans Genic Inc., Ltd.

List of Table

Table 01: Global Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 20132026
Table 02: Global Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 20132026
Table 03: Global Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 20132026
Table 04: Global Humanized Mice Model Market Size (US$ Mn) Forecast, by Region, 20132026
Table 05: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 20132026
Table 06: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 20132026
Table 07: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 20132026
Table 08: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 20132026
Table 09: Latin America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 20132026
Table 10: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 20132026
Table 11: North America Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 20132026
Table 12: Latin America Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 20132026
Table 13: Europe Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 20132026
Table 14: Europe Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 20132026
Table 15: Europe Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 20132026
Table 16: Europe Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 20132026
Table 17: Asia Pacific Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 20132026
Table 18: Asia Pacific Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 20132026
Table 19: Asia Pacific Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 20132026
Table 20: Asia Pacific Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 20132026
Table 21: MEA Humanized Mice Model Market Size (US$ Mn) and Forecast, by Country, 20132026
Table 22: MEA Humanized Mice Model Market Size (US$ Mn) and Forecast, by Model Type, 20132026
Table 23: MEA Humanized Mice Model Market Size (US$ Mn) and Forecast, by Application, 20132026
Table 24: MEA Humanized Mice Model Market Size (US$ Mn) and Forecast, by End User, 2013202

List of Chart

Figure 01: Global Humanized Mice Model Market Split By Model Type (2016A)
Figure 02: Global Humanized Mice Model Market Split By Application (2016A)
Figure 03: Global Humanized Mice Model Market Split By End User (2016A)
Figure 04: Global Humanized Mice Model Market Split By Region (2016A)
Figure 05: Global Humanized Mice Model Market Size (US$ Mn) Forecast and Y-o-Y Growth Rate (%), 20132026
Figure 06: Global Humanized Mice Model Market Absolute $ Opportunity, 20162026
Figure 07: Global Humanized Mice Model Market BPS Analysis, by Model Type, 2017 & 2025
Figure 08: Global Humanized Mice Model Y-o-Y Growth Rate (%), By Model Type, 20162026
Figure 09: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Genetic Humanized Mice Model
Figure 10: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell-Based Humanized Mice Model
Figure 11: Global Humanized Mice Model Market Attractiveness Analysis, by Model Type, 20172026
Figure 12: Global Humanized Mice Model Market BPS Analysis, by Application, 2017 & 2025
Figure 13: Global Humanized Mice Model Y-o-Y Growth Rate (%), By Application, 20162026
Figure 14: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Toxicology segment
Figure 15: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Oncology segment
Figure 16: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Infectious Disease segment
Figure 17: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by GvHD segment
Figure 18: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Regenerative Medicine segment
Figure 19: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Neurobiology segment
Figure 20: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by other applications segment
Figure 21: Global Humanized Mice Model Market Attractiveness Analysis, by Application, 20172026
Figure 22: Global Humanized Mice Model Market BPS Analysis, By End User, 2017 & 2025
Figure 23: Global Humanized Mice Model Y-o-Y Growth Rate (%), By End User, 20162026
Figure 24: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Biotechnology Companies 2015-2025
Figure 25: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Contract Research Organizations 20132026
Figure 26: Global Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic & Research Institutes, 20132026
Figure 27: Global Humanized Mice Model Market Attractiveness Analysis, by End User, 20172026
Figure 28: Global Humanized Mice Model Market BPS Analysis, by Region, 2017 & 2025
Figure 29: Global Humanized Mice Model Y-o-Y Growth Rate (%), by Region, 20162026
Figure 30: North America Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 31: Latin America Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 32: Europe Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 33: Asia-Pacific Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 34: Middle East & Africa Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 35: Global Humanized Mice Model Market Attractiveness Analysis, by Region, 20172026
Figure 36: North America Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
Figure 37: North America Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 20162026
Figure 38: U.S. Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 39: Canada Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 40: North America Humanized Mice Model Market Analysis by Model Type, 20172026
Figure 41: North America Humanized Mice Model Market Analysis by Application, 20172026
Figure 42: North America Humanized Mice Model Market Analysis by End Users, 20172026
Figure 43: North America Humanized Mice Model Market Analysis by Country, 20172026
Figure 44: Latin America Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
Figure 45: Latin America Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 20162026
Figure 46: Brazil Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 47: Mexico Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 48: Rest of Latin America Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 49: Latin America Humanized Mice Model Market Analysis by Model Type, 20172026
Figure 50: Latin America Humanized Mice Model Market Analysis by Application, 20172026
Figure 51: Latin America Humanized Mice Model Market Analysis by End User, 20172026
Figure 52: Latin America Humanized Mice Model Market Analysis by Country, 20172026
Figure 53: Europe Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
Figure 54: Europe Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 20162026
Figure 55: Germany Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 56: U.K. Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 57: France Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 58: Italy Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 59: Spain Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 60: Russia Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 61: Rest of Europe Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 62: Europe Humanized Mice Model Market Analysis by Model Type, 20172026
Figure 63: Europe Humanized Mice Model Market Analysis by Application, 20172026
Figure 64: Europe Humanized Mice Model Market Analysis by End User, 20172026
Figure 65: Europe Humanized Mice Model Market Analysis by Country, 20172026
Figure 66: Asia Pacific Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
Figure 67: Asia Pacific Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 20162026
Figure 68: China Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 69: Japan Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 70: India Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 71: ASEAN Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,
Figure 72: Australia & New Zealand Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 73: Rest of APAC Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 74: Asia Pacific Humanized Mice Model Market Analysis by Model Type, 20172026
Figure 75: Asia Pacific Humanized Mice Model Market Analysis by Application, 20172026
Figure 76: Asia Pacific Humanized Mice Model Market Analysis by End User, 20172026
Figure 77: Asia Pacific Humanized Mice Model Market Analysis by Country, 20172026
Figure 78: MEA Humanized Mice Model Market BPS Analysis, by Country, 2017 & 2025
Figure 79: MEA Humanized Mice Model Y-o-Y Growth Rate (%), by Country, 20162026
Figure 80: GCC Countries Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 81: South Africa Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 82: Rest of MEA Humanized Mice Model Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20132026
Figure 83: MEA Humanized Mice Model Market Analysis by Model Type, 20172026
Figure 84: MEA Humanized Mice Model Market Analysis by Application, 20172026
Figure 85: MEA Humanized Mice Model Market Analysis by End User, 20172026
Figure 86: MEA Humanized Mice Model Market Analysis by Country, 20172026

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *